Jeffrey S. Heier, Director at OCULAR THERAPEUTIX, INC (OCUL), bought 15,000 shares at $3.05 ($46K) on 2022-05-12, disclosed to the SEC on 2022-05-16.
Open-market purchase of $46k OCUL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| OCUL | SELL | 2026-05-28 | $25K | — | Filing → |
| OCUL | SELL | 2026-02-25 | $25K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $42K | — | Filing → |